已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes

医学 赛马鲁肽 二甲双胍 恩帕吉菲 利拉鲁肽 2型糖尿病 杜拉鲁肽 内科学 卡格列净 艾塞那肽 糖尿病 磷酸西他列汀 达帕格列嗪 药理学 胰岛素 内分泌学
作者
Απόστολος Τσάπας,Ioannis Avgerinos,Thomas Karagiannis,Konstantinos Malandris,Apostolos Manolopoulos,P Andréadis,Aris Liakos,David R. Matthews,Eleni Bekiari
出处
期刊:Annals of Internal Medicine [American College of Physicians]
卷期号:173 (4): 278-286 被引量:226
标识
DOI:10.7326/m20-0864
摘要

Background: Several pharmacologic options for type 2 diabetes are available. Purpose: To compare benefits and harms of glucose-lowering drugs in adults with type 2 diabetes. Data Sources: Several databases from inception through 18 December 2019 and ClinicalTrials.gov on 10 April 2020. Study Selection: English-language randomized trials that had at least 24 weeks of intervention and assessed the effects of glucose-lowering drugs on mortality, glycemic, and vascular outcomes. Data Extraction: Pairs of reviewers extracted data and appraised risk of bias. Data Synthesis: 453 trials assessing 21 antidiabetic interventions from 9 drug classes were included. Interventions included monotherapies (134 trials), add-on to metformin-based therapies (296 trials), and monotherapies versus add-on to metformin therapies (23 trials). There were no differences between treatments in drug-naive patients at low cardiovascular risk. Insulin regimens and specific glucagon-like peptide-1 receptor agonists (GLP-1 RAs) added to metformin-based background therapy produced the greatest reductions in hemoglobin A1c level. In patients at low cardiovascular risk receiving metformin-based background treatment (298 trials), there were no clinically meaningful differences between treatments for mortality and vascular outcomes. In patients at increased cardiovascular risk receiving metformin-based background treatment (21 trials), oral semaglutide, empagliflozin, liraglutide, extended-release exenatide, and dapagliflozin reduced all-cause mortality. Oral semaglutide, empagliflozin, and liraglutide also reduced cardiovascular death. Odds of stroke were lower with subcutaneous semaglutide and dulaglutide. Sodium–glucose cotransporter-2 (SGLT-2) inhibitors reduced heart failure hospitalization and end-stage renal disease. Subcutaneous semaglutide and canagliflozin increased diabetic retinopathy and amputation, respectively. Limitation: Inconsistent definitions of cardiovascular risk and low-level confidence in some estimates for patients at low cardiovascular risk. Conclusion: In diabetic patients at low cardiovascular risk, no treatment differs from placebo for vascular outcomes. In patients at increased cardiovascular risk receiving metformin-based background therapy, specific GLP-1 RAs and SGLT-2 inhibitors have a favorable effect on certain cardiovascular outcomes. Primary Funding Source: European Foundation for the Study of Diabetes, supported by an unrestricted educational grant from AstraZeneca. (PROSPERO: CRD42019122043)
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
给好评发布了新的文献求助10
5秒前
5秒前
科研的狗完成签到,获得积分20
6秒前
8秒前
顾北完成签到,获得积分10
9秒前
10秒前
12秒前
安生完成签到 ,获得积分20
12秒前
14秒前
英姑应助大麻花采纳,获得10
15秒前
16秒前
16秒前
17秒前
小叶完成签到 ,获得积分10
18秒前
眼睛大的断缘完成签到,获得积分10
18秒前
酷炫抽屉完成签到 ,获得积分10
19秒前
Mireia完成签到,获得积分10
20秒前
小七完成签到,获得积分10
20秒前
哲别发布了新的文献求助10
21秒前
平淡雪枫完成签到 ,获得积分10
21秒前
内向忆南发布了新的文献求助10
22秒前
科研发布了新的文献求助10
22秒前
雪梅完成签到 ,获得积分10
26秒前
Orange应助给好评采纳,获得10
27秒前
mangle完成签到,获得积分10
29秒前
内向忆南完成签到,获得积分10
30秒前
会飞的猪完成签到 ,获得积分10
31秒前
66完成签到,获得积分10
32秒前
34秒前
VISIN发布了新的文献求助10
39秒前
0201完成签到 ,获得积分10
40秒前
大模型应助科研采纳,获得10
44秒前
drift完成签到,获得积分10
45秒前
无情的友容完成签到 ,获得积分10
46秒前
46秒前
46秒前
hlw发布了新的文献求助10
51秒前
VISIN完成签到,获得积分10
52秒前
53秒前
黄毛虎完成签到 ,获得积分10
53秒前
高分求助中
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
Rechtsphilosophie 1000
Bayesian Models of Cognition:Reverse Engineering the Mind 888
Le dégorgement réflexe des Acridiens 800
Defense against predation 800
Very-high-order BVD Schemes Using β-variable THINC Method 568
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3136964
求助须知:如何正确求助?哪些是违规求助? 2787951
关于积分的说明 7783990
捐赠科研通 2443991
什么是DOI,文献DOI怎么找? 1299549
科研通“疑难数据库(出版商)”最低求助积分说明 625477
版权声明 600954